Adverse Drug Reactions: The Great Masqueraders

This is a preview of subscription content, access via your institution.


  1. 1.

    Vere, DW. Drug adverse reactions as masquereders. Adverse Drug Reaction Bull. 1976;60:208–211.

    Article  Google Scholar 

  2. 2.

    Ahmed, M, Davison, OW. Severe cystitis associated with tiaprofenic acid. Br Med, J. 1991;303:1376.

  3. 3.

    Ghose, K. Cystitis and nonsteroidal antiinflammatory drugs: an incidental association or an adverse effect? New Zealand Med, J. 1993;106:501–503.

    CAS  Google Scholar 

  4. 4.

    Greene, GF, Millard, OH, Norman, RW, Boudreau, SF, Auld, RB, Awad, SA. Cystitis associated with tiaprofenic acid. J Urol. 1994;152:1101–1102.

    CAS  Article  Google Scholar 

  5. 5.

    Harrison, WJ, Willis, RG, Neal, DE. Adverse reactions to tiaprofenic acid mimicking interstitial cystitis. Br Med, J. 1994;309:574.

    CAS  Article  Google Scholar 

  6. 6.

    O’Neil, GF. Tiaprofenic acid as a cause of non-bacterial cystitis. Med J Australia. 1994;160:123–125.

    Article  Google Scholar 

  7. 7.

    Anon. Severe cystitis with tiaprofenic acid (Surgam). Current Prob. 1994;21:11.

    Google Scholar 

  8. 8.

    Terol, MJ, Cervantes, F, Pereira, A, Rozman, C. Autoimmune hemolytic anaemia after 9 years of treatment with alphmethyldopa. (letter). Med Clin Bare. 1991:101:598.

    Google Scholar 

  9. 9.

    McKenzie, R, Fried, MW, Sallie, R, Conjeevaram, H, Di-Bisceglie, AM, Park, Y, Savarese, B, Kleiner, D, Tsokos, M, Luciano, C, et al. Hepatic failure and lactic acidosis due to fialuridine (FLAU), an investigational nucleoside analogue for chronic hepatitis, B. N Engl J Med. 1995;333(17):1099–1105.

    CAS  Article  Google Scholar 

  10. 10.

    Pepys, J, Pepys, EO, Baldo, BA, Whitwam, JG. Anaphylactic/anaphylactoid reactions to anaesthetic and associated agents. Skin prick tests in aetiological diagnosis. Anaesthetic. 1994;49:470–475.

    CAS  Article  Google Scholar 

  11. 11.

    Stephens, M. Deliberate drug rechallenge. Hum Toxicol. 1983;2(4):573–577.

    CAS  Article  Google Scholar 

  12. 12.

    Smith, PM, Wilton, A, Routledge, PA. Case report. Jaundice associated with amoxycillin—clavulonate potassium therapy. Eur J Gastroenterol Hepatol. 1991;3:95–96.

    Google Scholar 

  13. 13.

    Miros, M, Kerlin, P, Walker, N, Harris, O. Flucloxacillin induced delayed cholestatic hepatitis. Aust New Zealand J Med. 1990;20:251–253.

    CAS  Article  Google Scholar 

  14. 14.

    Davies, MH, Harrison, RF, Elias, E, Hubscher, SG. Antibiotic-associated acute vanishing bile duct syndrome; a pattern associated with severe, prolonged, intrahepatic cholestasis. J Hepatol. 1994;20:112–116.

    CAS  Article  Google Scholar 

  15. 15.

    Rawlins, MD. Pharmacovigilance: paradise lost, regained or postponed? J Roy Coll Physicians. 1995; 29:41–49.

    CAS  Google Scholar 

  16. 16.

    Bateman, DN, Sanders GLS, Rawlins, MD. Attitudes to adverse drug reaction reporting: The Northern Region. Br J Clin Pharmac. 1992;34:421–426.

    CAS  Article  Google Scholar 

  17. 17.

    Houghton, JE, Pinto Pereira, LM, Woods, FJ, Richens, A, Routledge, PA. The Welsh Adverse Drug Reactions Scheme; experience of a UK regional monitoring centre. Adverse Drug Reac Toxicol Rev. 1996; 15(2).

    Google Scholar 

  18. 18.

    Albengres, E, Gauthier, F, Tillement, JP. Current French system of post-marketing drug surveillance. Int J Clin Pharmacol Ther Toxicol. 1990;312–314.

    Google Scholar 

  19. 19.

    Begaud, B, Chaslerie, A, Haramburu, F. Organization and results of drug vigilance in France. Rev Epidemiol Sante Publique. 1994;42:416–423.

    CAS  PubMed  Google Scholar 

  20. 20.

    Edwards, IR, Lindquist, M, Wiholm, BE, Napke, E. Quality criteria for early signals of possible adverse drug reactions. Lancet. 1990;336:156–158.

    CAS  Article  Google Scholar 

  21. 21.

    Griffin, JP. Survey of the adverse drug reporting ode-mas in fifteen countries. Br J Clin Pharmacol. 1986; 22:835–1005.

    Article  Google Scholar 

  22. 22.

    Walker, RS, Linton, AL. Phenethyldiguanide: A dangerous side-effect. Br Med, J. 1959;2:1005–1006.

    CAS  Article  Google Scholar 

  23. 23.

    Chandalia, HB, Rangnath, M. Biguanide induced lactic acidosis. J Ass Physicians India. 1990;38:620–622.

    CAS  PubMed  Google Scholar 

  24. 24.

    McGuinness, ME, Talbert, RJ. Phenformin-induced lactic acidosis: a forgotten adverse drug reaction. Ann Pharmacother. 1993;27:1183–1187.

    CAS  Article  Google Scholar 

  25. 25.

    Soria-Royer, C, Legendre, C, Mircheva, J, Premel, S, Beaune, P, Kreis, H. Thiopurine-methyl transferase activity to assess azathioprine myeltoxicity in renal transplant recipients (letter). Lancet. 1993;341(8860) 1593–1594.

    CAS  Article  Google Scholar 

  26. 26.

    Evans DAP, Manley, KA, Makusick, VA. Genetic control of isoniazid metabolism in man. Br Med, J. 1960;2:485–491.

    CAS  Article  Google Scholar 

  27. 27.

    Adams, LE, Hess, EV. Drug-related lupus. Incidence, mechanisms and clinical implications. Drug Safety. 1991:6:431–449.

    CAS  Article  Google Scholar 

  28. 28.

    Hutchings, A, Routledge, PA. A simple method for determining acetylator phenotype using isoniazid. Br J Clin Pharmac. 1986;22:343–345.

    CAS  Article  Google Scholar 

  29. 29.

    Hutchings, A, Routledge, PA. A single sample sauva test to measure acetylator phenotype using isoniazid. Br J Clin Pharmac. 1996;42:635–637.

    CAS  Article  Google Scholar 

  30. 30.

    Bechtel, PR. Relevance and limits of pharmacogenetics to detect patients at risk of adverse drug reactions. Pharmacoepidem Drug Safety. 1995;4:31–36.

    Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Professor P. A. Routledge.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Routledge, P.A., Bialas, M.C., Houghton, J.E. et al. Adverse Drug Reactions: The Great Masqueraders. Ther Innov Regul Sci 32, 79–84 (1998).

Download citation